The Independent Neurorehabilitation Providers Alliance (INPA) has published a new paper, which reviews the use of repetitive transcranial magnetic stimulation (rTMS) to improve outcomes following a traumatic brain injury. The paper was published in ‘Neuropsychological Rehabilitation’ by Taylor and Francis on 27th December 2019 and is the result of a joint approach by INPA to promote high standards and best practice in the treatment, management and care of people requiring rehabilitation following brain or spinal injury.
‘The use of repetitive transcranial magnetic stimulation (rTMS) following traumatic brain injury (TBI): A scoping review’ and was developed by INPA’s Research group, which is led by Professor Nick Alderman and Dr Martine Stoffels, who has a special interest in this area and academic colleagues Associate Professor Claire Williams and Dr Aimee Pink from the Swansea University.
Repetitive transcranial magnetic stimulation (rTMS) is a neuromodulatory tool currently recommended by the National Institute for Health and Care Excellence as a treatment for depression. INPA’s considers the application of rTMS after traumatic brain injury focussing on its effect on a number of common issues. It also considers whether an optimal and safe rTMS protocol can be determined, and makes recommendations for future clinical and research work.
The paper concluded that rTMS holds promise as an effective treatment is effective for depression, dizziness, central pain, aphasia and visual neglect which often follow brain injury. However, for prolonged disorders of consciousness and other cognitive outcomes rTMS is less effective. Most patients’ experiences did not show side effects however a few reported some, including a few reports of seizures. INPA recommends that more comprehensive guidelines and further reporting of rTMS parameters and procedures are made.
The full paper can be viewed here https://www.tandfonline.com/doi/full/10.1080/09602011.2019.1706585
Professor Nick Alderman, Chair of INPA’s Research Group stated, “We are really pleased to have published this review. INPA is a very forward looking and collegiate organisation and we have managed to produce this work as a result of working together to improve outcomes for people with brain injury and other neurological conditions.”
Dr Martine Stoffels commented that “This is a new and exciting area of treatment and with further work we hope to show with defined guidance how rTMS can be used effectively.”
INPA is membership organisation for neurocare providers who work in the independent sector. Please see www.in-pa.org.uk for further details.